SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 24.6% | 27.3% | 30.9% | 11.6% | 10.8% | 13.2% | 13.2% | 5.5% | 45.9% | 40.5% | 38.9% | 32.1% | |
| 75.4% | 72.7% | 69.1% | 88.4% | 89.2% | 86.8% | 86.8% | 94.5% | 54.1% | 59.5% | 61.1% | 67.9% | |
| 17.4% | 14.1% | 17.5% | 11.8% | 9.5% | 9.9% | 9.5% | 0.8% | 29.6% | 76.9% | 74.9% | 56.0% | |
| 55.1% | 55.5% | 58.0% | 24.1% | 59.7% | 49.4% | 34.6% | 3.1% | 55.2% | 104.0% | 116.5% | 86.3% | |
| 72.3% | 67.2% | 67.7% | 62.3% | 69.5% | 58.8% | 44.6% | 3.9% | 85.0% | 181.5% | 231.5% | 143.3% | |
| 3.0% | 5.5% | 0.7% | 26.0% | 19.7% | 27.9% | 42.2% | 90.6% | -31.2% | -122.0% | -131.5% | -75.5% | |
| 5.4% | 2.8% | 2.4% | 0.9% | 0.5% | 0.3% | 0.3% | 0.0% | 0.1% | 0.5% | 1.6% | 2.5% | |
| 3.7% | 4.1% | -0.5% | 25.8% | 20.3% | 28.8% | 42.4% | 90.6% | 1.7% | -34.1% | 11.9% | -67.9% | |
| 3.3% | 4.4% | 3.7% | 4.8% | 4.6% | 2.3% | 6.2% | 16.0% | -4.2% | 23.5% | – | -16.4% | |
| -2.4% | -2.1% | -0.8% | 14.8% | 9.5% | 18.3% | 21.6% | 43.7% | 7.6% | -22.3% | 25.2% | -15.5% | |
| 22.0% | 16.2% | 12.6% | 29.4% | 22.9% | 30.9% | 43.4% | 91.1% | 12.3% | -1.3% | – | -48.6% |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.